Nykode Therapeutics ASA — Director's Dealing 2025

Nov 24, 2025

1	Details of the person discharging managerial responsibilities
a)	Name	Michael Engsig
b)	Position	Chief Executive Officer
2	Reason for notification
a)	Initial notification/ Amendment	Initial
3	Details of issuer
a)	Name	Nykode Therapeutics ASA
b)	LEI	254900UKQHWYZJD22017
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Shares in Nykode Therapeutics ASA (ISIN: NO0010714785)
b)	Nature of the transaction	Acquisition of shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 2.16	46,356
d)	Aggregated information	Price	NOK 2.16
	-Average price,	Volume	46,356
	aggregated volume and total amount	Total amount	NOK 100,128.96
e)	Date of the transaction	24.11.2025
f)	Place of the transaction	XOSL - Oslo Stock Exchange